For IL6 (Figure 3H), high expression indicates a poor prognosis in lung squamous cell carcinoma (LUSC) and BLCA, while demonstrating protective effects for KIRC, illustrating the dual aspects of cancer progression. Here, IL6 is linked to squamous cell lung carcinoma.